Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients G. BodeyD. Abi-SaidE. Whimbey Articles Pages: 625 - 634
Molecular epidemiological characteristics of pneumococcal meningitis in children R. F. KornelisseM. SluijterR. de Groot Articles Pages: 635 - 638
Predictive value of HIV-1 RNA detection in plasma by branched DNA assay during long-term zidovudine therapy L. CotteM. A. TrabaudC. Trepo Articles Pages: 639 - 645
Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction G. HallA. HeimdahlC. E. Nord Notes Pages: 646 - 649
Chronic meningitis due to herpes simplex virus in an immunocompetent host R. H. ChinB. C. RossP. D. R. Johnson Notes Pages: 650 - 653
Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources P. RiegelR. RuimyH. Monteil Notes Pages: 657 - 662
Laboratory detection of leucocyte esterase and nitrite as an alternative to urine microscopy B. I. F. BatchelorA. R. HuntD. W. M. Crook Letters Pages: 663 - 664
Comparison of direct and indirect immunofluorescence assays for rapid detection of cytomegalovirus in shell-vial culture J. ReinaM. MunarI. Blanco Letters Pages: 664 - 666
Activity of trovafloxacin against blood isolates ofStreptococcus pneumoniae in Sweden B. Olsson-LiljequistB. M. HoffmanJ. Hedlund OriginalPaper Pages: 671 - 675
Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters A. L. BarryP. C. FuchsS. D. Allen OriginalPaper Pages: 676 - 678
In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin P. C. FuchsA. L. BarryD. L. Sewell OriginalPaper Pages: 678 - 682
In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolates L. VerbistJ. Verhaegen OriginalPaper Pages: 683 - 685
In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia P. UrbáškováJ. TruplM. R. Jacobs OriginalPaper Pages: 686 - 688
In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin D. MilatovicC. Wallrauch OriginalPaper Pages: 688 - 693
Antibacterial activity of trovafloxacin against gram-positive blood culture isolates from nosocomial infections S. M. Hussain QadriY. Ueno OriginalPaper Pages: 694 - 696
In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens F. CrokaertM. AounJ. Klastersky OriginalPaper Pages: 696 - 698
